Smith Selected to Receive Lifetime Achievement Award for Migraine Research
Robert Smith, MD, professor emeritus in the department of family and community medicine, has been selected to receive the American Headache Societys (AHS) Lifetime Achievement Award, the societys highest honor, for recognition of his service to the society and to the field of headache medicine.
The award will be presented to Smith at the AHS 54th Annual Scientific Meeting in Los Angeles June 21, 2012.
Smith has played a leading role nationally and internationally in migraine headache research dating from the early 1950s. As a general practitioner in England, he won the British Medical Association Hawthorne prize for research on pain sensitivity, was a researcher with the Wellcome Foundation on migraine from 1960-63 and played an integral role in the formation of the Migraine Trust"the most prominent world organization promoting migraine research, says Smithin 1965.
Smith continued his headache research in family medicine after immigrating to the United States in 1967. He was an active member of the AHS and on its board, representing primary care practitioners, and was the founder and past director of the UC Headache Center.
He came to the University of Cincinnati in 1975 to establish the department of family medicine and was subsequently named the first Fred Lazarus Jr. Professor of Family Medicine at UC. Before coming to Cincinnati, he established the family medicine department at the University of North Carolina at Chapel Hill, one of the first family medicine departments in the U.S.
I was surprised, delighted and proud, Smith says about learning of being honored with this award. "The fact that they gave this award to a family physician was something I was very happy about as well.
Robert Smith, MD, founder of the UC Headache Center
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.